131 related articles for article (PubMed ID: 38123919)
1. CD7 activation regulates cytotoxicity-driven pathology in systemic sclerosis, yielding a target for selective cell depletion.
Papadimitriou TI; Singh P; van Caam A; Walgreen B; Gorris MAJ; Vitters EL; van Ingen IL; Koenders MI; Smeets RL; Vonk M; de Vries JM; van der Kraan PM; van Oosterhout Y; Huynen MA; Koenen HJPM; Thurlings RM
Ann Rheum Dis; 2024 Mar; 83(4):488-498. PubMed ID: 38123919
[TBL] [Abstract][Full Text] [Related]
2. The effect of a chimeric mouse-human CD7 antibody on human T, natural killer, and lymphokine-activated killer cell activity in vitro.
Akbar AN; Amlot PL; Hawkins C; Newsholme W; Delaney S; Borthwick N; Janossy G
Transplantation; 1991 Aug; 52(2):325-30. PubMed ID: 1714642
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of T cell antigens in normal peripheral blood lymphocytes: a quantitative analysis by flow cytometry.
Ginaldi L; Farahat N; Matutes E; De Martinis M; Morilla R; Catovsky D
J Clin Pathol; 1996 Jul; 49(7):539-44. PubMed ID: 8813949
[TBL] [Abstract][Full Text] [Related]
4. T and NK Cell Phenotypic Abnormalities in Systemic Sclerosis: a Cohort Study and a Comprehensive Literature Review.
Almeida I; Silva SV; Fonseca AR; Silva I; Vasconcelos C; Lima M
Clin Rev Allergy Immunol; 2015 Dec; 49(3):347-69. PubMed ID: 26445774
[TBL] [Abstract][Full Text] [Related]
5. The immunobiology of systemic sclerosis.
Gu YS; Kong J; Cheema GS; Keen CL; Wick G; Gershwin ME
Semin Arthritis Rheum; 2008 Oct; 38(2):132-60. PubMed ID: 18221988
[TBL] [Abstract][Full Text] [Related]
6. [Application of lymphocytes test in peripheral blood of patients with systemic sclerosis during the treatment].
Ma XB; Zhang XW; Jia RL; Gao Y; Liu HJ; Liu YF; Li YN
Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Aug; 53(4):721-727. PubMed ID: 34393235
[TBL] [Abstract][Full Text] [Related]
7. Cell surface expression of activating receptors and co-receptors on peripheral blood NK cells in systemic autoimmune diseases.
Puxeddu I; Bongiorni F; Chimenti D; Bombardieri S; Moretta A; Bottino C; Migliorini P
Scand J Rheumatol; 2012 Aug; 41(4):298-304. PubMed ID: 22632143
[TBL] [Abstract][Full Text] [Related]
8. Human T lymphocyte differentiation antigens as target for immunotoxins or complement-mediated cytotoxicity.
Preijers FW; De Witte T; Rijke-Schilder GP; Tax WJ; Wessels JM; Haanen C; Capel PJ
Scand J Immunol; 1988 Aug; 28(2):185-94. PubMed ID: 3261884
[TBL] [Abstract][Full Text] [Related]
9. Autoimmunity in systemic sclerosis: current concepts.
Boin F; Rosen A
Curr Rheumatol Rep; 2007 May; 9(2):165-72. PubMed ID: 17502048
[TBL] [Abstract][Full Text] [Related]
10. Expression and function of CD7 molecule on human natural killer cells.
Rabinowich H; Pricop L; Herberman RB; Whiteside TL
J Immunol; 1994 Jan; 152(2):517-26. PubMed ID: 7506726
[TBL] [Abstract][Full Text] [Related]
11. Identification of a novel subpopulation of human cord blood CD34-CD133-CD7-CD45+lineage- cells capable of lymphoid/NK cell differentiation after in vitro exposure to IL-15.
Rutella S; Bonanno G; Marone M; De Ritis D; Mariotti A; Voso MT; Scambia G; Mancuso S; Leone G; Pierelli L
J Immunol; 2003 Sep; 171(6):2977-88. PubMed ID: 12960322
[TBL] [Abstract][Full Text] [Related]
12. Optimized quantification of lymphocyte subsets by use of CD7 and CD33.
Hauser A; Schrattbauer K; Najdanovic D; Schlossnickel R; Koch A; Hejtman M; Krugluger W
Cytometry A; 2013 Mar; 83(3):316-23. PubMed ID: 23315982
[TBL] [Abstract][Full Text] [Related]
13. Reduced circulating natural killer T cells and gamma/delta T cells in patients with systemic sclerosis.
Riccieri V; Parisi G; Spadaro A; Scrivo R; Barone F; Moretti T; Bernardini G; Strom R; Taccari E; Valesini G
J Rheumatol; 2005 Feb; 32(2):283-6. PubMed ID: 15693088
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the Fc mu receptor on human natural killer cells. Interaction with its physiologic ligand, human normal IgM, specificity of binding, and functional effects.
Pricop L; Rabinowich H; Morel PA; Sulica A; Whiteside TL; Herberman RB
J Immunol; 1993 Sep; 151(6):3018-29. PubMed ID: 7690792
[TBL] [Abstract][Full Text] [Related]
15. A combination of anti-CD3 and anti-CD7 ricin A-immunotoxins for the in vivo treatment of acute graft versus host disease.
van Oosterhout YV; van Emst L; Schattenberg AV; Tax WJ; Ruiter DJ; Spits H; Nagengast FM; Masereeuw R; Evers S; de Witte T; Preijers FW
Blood; 2000 Jun; 95(12):3693-701. PubMed ID: 10845899
[TBL] [Abstract][Full Text] [Related]
16. Lymphokine-activated killer cell and natural killer cell activities in patients with systemic sclerosis.
Kantor TV; Whiteside TL; Friberg D; Buckingham RB; Medsger TA
Arthritis Rheum; 1992 Jun; 35(6):694-9. PubMed ID: 1376124
[TBL] [Abstract][Full Text] [Related]
17. Human fetal liver-derived CD7+CD2lowCD3-CD56- clones that express CD3 gamma, delta, and epsilon and proliferate in response to interleukin-2 (IL-2), IL-3, IL-4, or IL-7: implications for the relationship between T and natural killer cells.
Hori T; Phillips JH; Duncan B; Lanier LL; Spits H
Blood; 1992 Sep; 80(5):1270-8. PubMed ID: 1381242
[TBL] [Abstract][Full Text] [Related]
18. Targeting Costimulatory Pathways in Systemic Sclerosis.
Boleto G; Allanore Y; Avouac J
Front Immunol; 2018; 9():2998. PubMed ID: 30619351
[TBL] [Abstract][Full Text] [Related]
19. Increased CD8+ tissue resident memory T cells, regulatory T cells and activated natural killer cells in systemic sclerosis lungs.
Padilla CM; Valenzi E; Tabib T; Nazari B; Sembrat J; Rojas M; Fuschiotti P; Lafyatis R
Rheumatology (Oxford); 2024 Mar; 63(3):837-845. PubMed ID: 37310903
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of CD3 and CD7 in T-cell malignancies: a quantitative study by flow cytometry.
Ginaldi L; Matutes E; Farahat N; De Martinis M; Morilla R; Catovsky D
Br J Haematol; 1996 Jun; 93(4):921-7. PubMed ID: 8703826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
